Schedule 13G ownership disclosure

BIOCRYST PHARMACEUTICALS INC

Security class unavailable · CUSIP: 09058V103

Event date: 2020-04-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,500,000
Percent of class
1.6200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-20-001843
Form type
SC 13G
Filer
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK
CIK 1165408
Filed
Apr 17, 2020
Reporting period
Apr 08, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub